Skip to main content
Figure 2 | Breast Cancer Research

Figure 2

From: Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo

Figure 2

Focal adhesion kinase (FAK)-negative mammary epithelial neoplastic cells show a reduced proliferative capacity. (a) FAK and Neu expression in FAKwt/wt (left) and FAKflox/flox (right)/mouse mammary tumour virus (MMTV)-Cre/-NDL2-5 end-stage mammary tumours was determined by immunoblotting. Cytokeratin 8 (CK8) was used as a control for epithelial content. β-actin was used as a loading control. (b) Immunohistochemistry analyses of Cre (left) and FAK (right) expression on paraffin sections of end-stage mammary tumours from FAKwt/wt (upper) and FAKflox/flox (lower)/MMTV-Cre/-NDL2-5 animals. Data are representative of at least five animals from each genotype. FAK is co-expressed with Cre throughout the MMTV-Cre/-NDL2-5-derived solid tumour tissue. In FAKflox/flox tumour sections, Cre-positive/FAK-negative cells are detectable only in small hyperplastic or non-transformed ductal structures. (Scale bars: 100 μm). (c) Paraffin sections of hyperplastic mammary glands from 6-month-old FAKwt/wt and FAKflox/flox/MMTV-Cre/-NDL2-5 mice were submitted to immunohistofluorescence analyses of Cre and Ki67 expression. (Scale bars: 20 μm). (d) Graphical representation of the immunostaining shown in (c). Percentages (± standard error of the mean, SEM) were calculated after counting multiple fields from at least five animals from each genotype. P <0.01 vs. FAKwt/wt mice, Student's t-test.

Back to article page